Front Page News
Cure SMA Announces Additional $315,000 for SMA Drug Program at The California Institute of Biomedical Research
Cure SMA is pleased to announce that we have extended our spinal muscular atrophy research program with the California Institute of Biomedical Research (CALIBR) with […]
Cure SMA Releases Updated Overview of Research Model
When Cure SMA first started funding research thirty years ago, we had to build up from virtually nothing. It’s no easy task. Drug development relies […]
Cure SMA Hosts SMA Researcher Meeting this June
The Annual SMA Conference consists of two separate events that run in parallel. The first is focused on families affected by SMA, who gather for […]
How Our Cure SMA Community is Raising Awareness
Spinal muscular atrophy is the number one genetic cause of death for infants, and 1 in 50 people carry the genetic mutation that causes SMA. […]
Updates on Pharmaceutical Companies Investing in SMA Drug Development
Over the past decade, one of the most important advances in SMA drug development has been the number of pharmaceutical companies investing in treatments for […]
Cure SMA Awards $140,000 Grant to Francesco Lotti, PhD, of Columbia University
Cure SMA has awarded a $140,000 research grant to Francesco Lotti, PhD, at Columbia University, for his project, “Role of Sumoylation in SMN Function and […]
21st Century Cures Discussion Document Released
The US House of Representatives Energy and Commerce Committee has released the 21st Century Cures discussion document. The 21st Century Cures initiative was created to […]
Cure SMA-Funded Researcher Publishes Paper on Critical Issues for SMA Families and Doctors
Matthew A. Halanski, a Cure SMA-funded researcher from University of Wisconsin – Madison, was the lead author on, “Assessing the Needs of the SMA Population,” […]
Join Cure SMA in Celebrating the International Day of Acceptance
January 20 is a day dedicated to the social acceptance of disability and to honor the late Annie Hopkins, SMA type II, who is the […]
Roche Buys Trophos to Continue Work on SMA Drug
Swiss drugmaker Roche has agreed to buy privately-held Trophos. Roche, the third largest pharmaceutical company in the world, will now bring its resources to help […]